BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7710905)

  • 1. Role of gene amplification in drug resistance.
    Schoenlein PV
    Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional regulation of multidrug resistance gene expression.
    Thorgeirsson SS; Gant TW; Silverman JA
    Cancer Treat Res; 1994; 73():57-68. PubMed ID: 7710910
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro models of multiple drug resistance.
    Greenberger LM; Cohen D; Horwitz SB
    Cancer Treat Res; 1994; 73():69-106. PubMed ID: 7710911
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants.
    Pirity M; Hevér-Szabó A; Venetianer A
    Cytotechnology; 1996; 19(3):207-14. PubMed ID: 8862008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unanswered questions about multidrug resistance.
    Beck WT
    Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical reversal of multidrug resistance.
    Sikic BI; Fisher GA; Lum BL; Brophy NA; Yahanda AM; Adler KM; Halsey J
    Cancer Treat Res; 1994; 73():149-65. PubMed ID: 7710904
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcriptional regulation of multidrug resistance in breast cancer.
    Glazer RI; Rohlff C
    Breast Cancer Res Treat; 1994; 31(2-3):263-71. PubMed ID: 7881104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of protein kinase C in multidrug resistance.
    O'Brian CA; Ward NE; Gravitt KR; Fan D
    Cancer Treat Res; 1994; 73():41-55. PubMed ID: 7710909
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA; Bagrij T; Neo SY
    Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of multidrug resistance.
    Herzog CE; Bates SE
    Cancer Treat Res; 1994; 73():129-47. PubMed ID: 7710903
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug resistance in human cancer.
    Goldstein LJ; Pastan I; Gottesman MM
    Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
    [No Abstract]   [Full Text] [Related]  

  • 15. Cloning, transfer, and characterization of multidrug resistance protein.
    Grant CE; Bhardwaj G; Cole SP; Deeley RG
    Methods Enzymol; 1998; 292():594-607. PubMed ID: 9711585
    [No Abstract]   [Full Text] [Related]  

  • 16. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies.
    Kuwano M; Uchiumi T; Hayakawa H; Ono M; Wada M; Izumi H; Kohno K
    Cancer Sci; 2003 Jan; 94(1):9-14. PubMed ID: 12708467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo models of P-glycoprotein-mediated multidrug resistance.
    Gottesman MM; Mickisch GH; Pastan I
    Cancer Treat Res; 1994; 73():107-28. PubMed ID: 7710902
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance in breast cancer--is the jury in yet?
    Kaye SB
    J Natl Cancer Inst; 1997 Jul; 89(13):902-3. PubMed ID: 9214663
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of the MDR1 gene in human cancers.
    Goldstein LJ; Gottesman MM; Pastan I
    Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.